After many years, Battlestar Galactica series creator Ronald D. Moore finally confirmed the mystery behind Starbuck's ...

For all its complexity and depth, one enduring Battlestar Galactica mystery's solution is leaving many fans disappointed.

In a challenging year for biotech firms, Pyxis Oncology’s stock has touched a new 52-week low, sinking to $0.98. According to... Tuesday, Pyxis Oncology Inc. (NASDAQ:PYXS) saw its price target ...

BOSTON, May 14, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation ADC therapeutics for difficult-to-treat cancers, today announced ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Story March 18 - Pyxis Oncology: Having recently trimmed back its pipeline to a sole cancer candidate, Pyxis Oncology has now reduced its head count to match. The Boston biotech is shrinking its ...